epiH :: Epidemiology and Health

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Quantifying the duration of the preclinical detectable phase in cancer screening: a systematic review

Sandra M. E. Geurts, Anne M. W. M. Aarts, André L. M. Verbeek, Tony H. H. Chen, Mireille J. M. Broeders, Stephen W. Duffy

Epidemiol Health. 2022;44:e2022008 Published online January 3, 2022
DOI: https://doi.org/10.4178/epih.e2022008

Sensitivity, effect and overdiagnosis in screening for cancers with detectable pre-invasive phase

Matti Hakama, Arun Pokhrel, Nea Malila, Timo Hakulinen

International Journal of Cancer. 2014;136(4):928-935

Link1

Mammographic screening only matters in the detectable preclinical period of breast cancer

MJM Broeders, ALM Verbeek

Journal of Medical Screening. 2005;12(2):107-108

Link1 Link2

Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase

Stephen W. Duffy, Hsiu-Hsi Chen, Laszlo Tabar, Nicholas E. Day

Statistics in Medicine. 1995;14(14):1531-1543

Link1 Link2

The Phase III Cancer Clinical Trial

Emil Frei

Anticancer Drug Development Guide. 1997;289-292

Link1

Estimation of the Duration of the Preclinical Phase of Cervical Adenocarcinoma Suggests That There Is Ample Opportunity for Screening

Steven C. Plaxe, Sidney L Saltzstein

Gynecologic Oncology. 1999;75(1):55-61

Link1 Link2

Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology

Theodora M Ripping, Kevin ten Haaf, André L M Verbeek, Nicolien T van Ravesteyn, Mireille J M Broeders

JNCI: Journal of the National Cancer Institute. 2017;109(10):

Link1

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

M E van den Akker-van Marie, M van Ballegooijen, L Rozendaal, C J L M Meijer, J D F Habbema

British Journal of Cancer. 2003;89(10):1830-1833

Link1

Link2 Link3

Barriers and Facilitators for Cervical Cancer Screening Among Young Women: A Systematic Review

. 2021;

Link1 Link2

A Systematic Review on Evolving the Bowel Cancer Screening Programme in England: Targeted Screening for Individuals with First-Degree Family History of Bowel Cancer

Rutendo Lisa Chigonda

. 2022;

Link1 Link2

Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer

A.M.W.M. Aarts, S.W. Duffy, S.M.E. Geurts, D.P. Vulkan, N. Houssami, M. Zappa, I.D. Nagtegaal, A.L.M. Verbeek, M.J.M. Broeders

The Breast. 2019;45:70-74

Link1 Link2